AbCellera Biologics Inc (ABCL) Looks Ready for Growth Despite -26.96% Change This Year

AbCellera Biologics Inc (NASDAQ: ABCL) is -26.96% lower on its value in year-to-date trading and has touched a low of $1.89 and a high of $4.20 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABCL stock was last observed hovering at around $2.02 in the last trading session, with the day’s gains setting it 0.12%.

Currently trading at $2.14, the stock is 4.85% and -4.30% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.02 million and changing 5.94% at the moment leaves the stock -19.36% off its SMA200. ABCL registered -47.55% loss for a year compared to 6-month loss of -24.38%. The firm has a 50-day simple moving average (SMA 50) of $2.241 and a 200-day simple moving average (SMA200) of $2.656375.

The stock witnessed a -14.06% gain in the last 1 month and extending the period to 3 months gives it a -9.32%, and is 8.63% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.06% over the week and 3.55% over the month.

AbCellera Biologics Inc (ABCL) has around 596 employees, a market worth around $638.76M and $23.12M in sales. Profit margin for the company is -726.23%. Distance from 52-week low is 13.19% and -49.05% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.45%).

The EPS is expected to shrink by -13.51% this year.

AbCellera Biologics Inc (ABCL) Top Institutional Holders

179.0 institutions hold shares in AbCellera Biologics Inc (ABCL), with institutional investors hold 58.04% of the company’s shares. The shares outstanding are 298.36M, and float is at 223.95M with Short Float at 10.05%. Institutions hold 44.71% of the Float.

The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.3556% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $64.86 million to account for 7.4472 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.62 million shares representing 3.611% and valued at over $31.45 million, while CAPITAL WORLD INVESTORS holds 1.8078 of the shares totaling 5.32 million with a market value of $15.74 million.

AbCellera Biologics Inc (ABCL) Insider Activity

#####

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.